Advertisement

The Scientist

» multiple sclerosis

Most Recent

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: TB Vaccine Protects Against MS

TB Vaccine Protects Against MS

By | December 10, 2013

A vaccine developed to ward off tuberculosis may help prevent symptoms of multiple sclerosis, according to a new study.

0 Comments

image: Opinion: Predicting Perfect Storms

Opinion: Predicting Perfect Storms

By | October 30, 2013

On embracing technology and collaboration to tackle brain disorders like multiple sclerosis

0 Comments

image: Top GSK Scientist Fired Over Paper

Top GSK Scientist Fired Over Paper

By | June 19, 2013

The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.

0 Comments

image: Salt at Fault?

Salt at Fault?

By | March 6, 2013

Two groups of researchers independently showed that high salt exposure stimulates cells implicated in multiple sclerosis and other autoimmune diseases.

3 Comments

image: Neuroscientist Falsifies Data?

Neuroscientist Falsifies Data?

By | August 9, 2012

An investigation of a well-known Dutch brain researcher finds evidence that she misrepresented data in 15 papers, but she is refuting the findings.

2 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

image: Suspected Effects of Vitamin D

Suspected Effects of Vitamin D

By | March 1, 2012

Vitamin D has a variety of actions in the body. It binds to the vitamin D receptor (VDR), which then binds to the retinoid X receptor (RXR) and activates the expression of numerous genes. 

0 Comments

image: Vitamin D on Trial

Vitamin D on Trial

By | March 1, 2012

Prevention trials for vitamins and supplements are notoriously difficult, but some researchers aren’t giving up on finding proof that vitamin D helps ward off disease.

52 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Opinion: Engineering the Epigenome
  4. Psychology’s Failure to Replicate
Advertisement
Life Technologies